You are here

bankruptcy

FDA rejects Clovis' long-shot bid for approval of Rubraca

FDA rejects Clovis' long-shot bid for approval of Rubraca

Fierce Pharma

Clovis Oncology

Flag link:

Sacklers win appeal that shields them from opioid lawsuits, clearing way for bankruptcy settlement

Sacklers win appeal that shields them from opioid lawsuits, clearing way for bankruptcy settlement

Stat

Flag link:

Pear Therapeutics assets sold for $6M at auction after bankruptcy

Pear Therapeutics assets sold for $6M at auction after bankruptcy

Mobihealthnews

Pear Therapeutics

digital therapeutics

Click Therapeutics

Nox Health Group

Flag link:

Athenex files for bankruptcy, seeks buyer for natural killer cell therapy unit

Athenex files for bankruptcy, seeks buyer for natural killer cell therapy unit

Fierce Biotech

natural killer cells

Flag link:

Envision bankruptcy could be 1st canary in the physician services coal mine

Envision bankruptcy could be 1st canary in the physician services coal mine

Radiology Business

Envision Healthcare

Flag link:

Martin Shkreli-founded drug company files for bankruptcy

Martin Shkreli-founded drug company files for bankruptcy

Reuters

Vyera Pharmaceuticals

Flag link:

Judge orders J&J, talc opponents to engage in settlement talks

Judge orders J&J, talc opponents to engage in settlement talks

Fierce Pharma

Flag link:

Shuttered Akorn recalls all its After shutting down, Akorn recalls its 70-plus products nationwidepharmaceuticals

Shuttered Akorn recalls all its After shutting down, Akorn recalls its 70-plus products nationwidepharmaceuticals

BioSpace

Flag link:

Is Pear’s demise a sign of things to come for digital therapeutics?

Is Pear’s demise a sign of things to come for digital therapeutics?

Pharmaphorum

Pear Therapeutics

digital therapeutics

Flag link:

Clovis sells off remaining assets—including cancer drug Rubraca—for $70M-plus

Clovis sells off remaining assets—including cancer drug Rubraca—for $70M-plus

Fierce Pharma

Clovis Oncology

Pharma & Schweiz

Flag link:

After Johnson & Johnson loses again in bankruptcy case, it's game on for talc lawsuits

After Johnson & Johnson loses again in bankruptcy case, it's game on for talc lawsuits

Fierce Pharma

Flag link:

Codiak files for Chapter 11 bankruptcy as most executives head for the exit

Codiak files for Chapter 11 bankruptcy as most executives head for the exit

Endpoints

Codiak Biosciences

Flag link:

After appeals loss, Johnson & Johnson will take Texas two-step case to the US Supreme Court

After appeals loss, Johnson & Johnson will take Texas two-step case to the US Supreme Court

Fierce Pharma

Flag link:

The FDA has cleared the first home flu and Covid test — but its maker just declared bankruptcy

The FDA has cleared the first home flu and Covid test — but its maker just declared bankruptcy

Stat

Flag link:

Tangled in bankruptcy proceedings and legal tussle, Sorrento secures $75M to stay afloat

Tangled in bankruptcy proceedings and legal tussle, Sorrento secures $75M to stay afloat

Endpoints

Sorrento Therapeutics

Flag link:

Judge indicates intention to dismiss J&J talc unit bankruptcy

Judge indicates intention to dismiss J&J talc unit bankruptcy

Reuters

Flag link:

Why Sorrento Therapeutics Stock Is Crashing Today

Why Sorrento Therapeutics Stock Is Crashing Today

Motley Fool

Sorrento Therapeutics

Flag link:

Amid bankruptcy, Clovis reveals more regulatory troubles for Rubraca

Amid bankruptcy, Clovis reveals more regulatory troubles for Rubraca

Fierce Pharma

Clovis Oncology

Flag link:

Appeals court tosses J&J's controversial 'Texas two-step' bankruptcy case

Appeals court tosses J&J's controversial 'Texas two-step' bankruptcy case

Endpoints

Flag link:

Medtronic wearable partner files for bankruptcy but plans to continue ‘without interruption’

Medtronic wearable partner files for bankruptcy but plans to continue ‘without interruption’

Medtech Dive

Rockley Photonics

Flag link:

Pages